HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Theses >
博士 (医学) >

小児骨粗鬆症における抗Siglec-15抗体療法の治療効果および安全性に関する研究

Files in This Item:
Dai_Sato.pdf23.98 MBPDFView/Open
Please use this identifier to cite or link to this item:https://doi.org/10.14943/doctoral.k14065
Related Items in HUSCAP:

Title: 小児骨粗鬆症における抗Siglec-15抗体療法の治療効果および安全性に関する研究
Other Titles: Studies on the efficacy and safety of anti-Siglec-15 Ab therapy in juvenile osteoporosis
Authors: 佐藤, 大1 Browse this author
Authors(alt): Sato, Dai1
Issue Date: 25-Mar-2020
Description: 配架番号:2530
Conffering University: 北海道大学
Degree Report Number: 甲第14065号
Degree Level: 博士
Degree Discipline: 医学
Examination Committee Members: (主査) 教授 山本 有平, 教授 近藤 英司, 教授 田中 真樹, 教授 生駒 一憲
Degree Affiliation: 医学研究科(医学専攻)
(Relation)haspart: D. Sato, M. Takahata, M. Ota, C. Fukuda, E. Tsuda, T. Shimizu, A. Okada, Y. Hiruma, H. Hamano, S. Hiratsuka, R. Fujita, N. Amizuka, T. Hasegawa, N. Iwasaki Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth Bone, 116. 172-180, (2018)
Type: theses (doctoral)
URI: http://hdl.handle.net/2115/77907
Appears in Collections:課程博士 (Doctorate by way of Advanced Course) > 医学院(Graduate School of Medicine)
学位論文 (Theses) > 博士 (医学)

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 

 - Hokkaido University